Articles
Volume 11 Supplement 1
VIII Madrid Breast Cancer Conference: Latest Advances in Breast Cancer
- Meeting abstracts
- from VIII Madrid Breast Cancer Conference: Latest Advances in Breast Cancer
- Madrid, Spain
- 24-26 June 2009
- The organisers would like to thank MSD for funding publication of this abstract supplement.
|
Oral presentation
Identifying and assessing women at high risk for breast cancer JE Garber Breast Cancer Research 2009, 11(Suppl 1):S1 (23 June 2009) |
|
Oral presentation
Magnetic resonance imaging for diagnosis, staging, and follow-up M Morrow Breast Cancer Research 2009, 11(Suppl 1):S2 (23 June 2009) |
|
Oral presentation
Genetic profile sets: differences and preferences M Vijver Breast Cancer Research 2009, 11(Suppl 1):S3 (23 June 2009) |
|
Oral presentation
Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design L Pusztai Breast Cancer Research 2009, 11(Suppl 1):S4 (23 June 2009) |
|
Oral presentation
Clinical utility and future of genetic profiles for breast cancer C Hudis Breast Cancer Research 2009, 11(Suppl 1):S5 (23 June 2009) |
|
Oral presentation
Axillary staging: new approaches and treatment of minimal disease MTFD Vrancken Peeters Breast Cancer Research 2009, 11(Suppl 1):S6 (23 June 2009) |
|
Oral presentation
EP Mamounas Breast Cancer Research 2009, 11(Suppl 1):S7 (23 June 2009) |
|
Oral presentation
Immediate versus delayed repair of partial mastectomy defects in breast conservation SJ Kronowitz, KK Hunt, H Kuerer, E Strom, TA Buchholz, JE Ensor, CA Koutz, GL Robb Breast Cancer Research 2009, 11(Suppl 1):S8 (23 June 2009) |
|
Oral presentation
Prophylactic contralateral surgery: current recommendations and techniques M Morrow Breast Cancer Research 2009, 11(Suppl 1):S9 (23 June 2009) |
|
Oral presentation
Other new radiotherapy techniques SC Formenti Breast Cancer Research 2009, 11(Suppl 1):S10 (23 June 2009) |
|
Oral presentation
Biomarkers and predictive factors of response to neoadjuvant treatment M Dowsett, A Dunbier, H Anderson, J Salter, S Detre, R Jones, A Skene, M Dixon, IE Smith Breast Cancer Research 2009, 11(Suppl 1):S11 (23 June 2009) |
|
Oral presentation
Adjuvant therapy after preoperative treatment for breast cancer E Ciruelos Breast Cancer Research 2009, 11(Suppl 1):S12 (23 June 2009) |
|
Oral presentation
Adjuvant therapy of HER2+ breast cancer EP Winer Breast Cancer Research 2009, 11(Suppl 1):S13 (23 June 2009) |
|
Oral presentation
Controversies in hormonal adjuvant therapy for premenopausal patients A Howell Breast Cancer Research 2009, 11(Suppl 1):S14 (23 June 2009) |
|
Oral presentation
Controversies in the hormonal adjuvant therapy of postmenopausal patients M Dowsett Breast Cancer Research 2009, 11(Suppl 1):S15 (23 June 2009) |
|
Oral presentation
Targeting the tumour microenvironment: denosumab, a new RANKL inhibitor RE Coleman Breast Cancer Research 2009, 11(Suppl 1):S16 (23 June 2009) |
|
Oral presentation
Bisphosphonates in the adjuvant treatment of early breast cancer M Gnant Breast Cancer Research 2009, 11(Suppl 1):S17 (23 June 2009) |
|
Oral presentation
Breast tumor heterogeneity: causes and consequences K Polyak, M Shipitsin, LL Campbell-Marrotta, N Bloushtain-Qimron, So Park Breast Cancer Research 2009, 11(Suppl 1):S18 (23 June 2009) |
|
Oral presentation
H Cortés-Funes, C Mendiola, L Manso, E Ciruelos Breast Cancer Research 2009, 11(Suppl 1):S19 (23 June 2009) |
|
Oral presentation
Future role of bevacizumab in breast cancer PF Conte, S Giovannelli Breast Cancer Research 2009, 11(Suppl 1):S20 (23 June 2009) |
